SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Huth who wrote (1151)8/20/1998 8:42:00 AM
From: wolfdog2   of 1491
 
Richard, I pretty much agree with your sentiments regarding the significance of the insider purchase and the script data. I wouldn't draw any inferences from the action of the share price, however. You need to look at biotechs as a universe. Strangely enough, even though biotech companies are not in a any way fungible, the group tends to move together. Biotechs are currently in the bargain basement. Take a look at CORR and COB (both with commercialized products) or LGND and ISIP (with soon to be commercialized products) for example

If we get a major market decline, PARS could move lower still. I would see that as a major buying opportunity.

OT: For anyone looking for another biotech investment, Columbia Labs (COB) is worth investigating. The stock has been under tremendous pressure from the shorts for some time. A dissident group has recently taken a large position in the company. Their express goal is to increase shareholder value. The company has several commercialized products, the most important one is Crinone. COB could easily earn over $1. The stock currently sells for less than 6. Anyone interested should check the SI COB board. Not long ago I wrote an analysis of the company's prospects and posted it on the COB board.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext